This product is not intended for human or animal consumption, diagnosis, or treatment
However, certain circumstances may warrant testing including pre-existing liver or kidney conditions where monitoring organ function during therapy provides appropriate oversight, specific health concerns that might benefit from objective biomarker assessment, desire to objectively measure oxidative stress markers or glutathione status before and during therapy, and medical conditions requiring monitoring for safety reasons
References Saha, S., Chant, D., Welham, J
protect from light and moisture Solubility: Sterile water, PBS, or suitable laboratory buffer (dissolves readily at neutral pH) Distributed by: Peptides Lab UK Quality assurance: Rigorous batch-level analysis
Zheng S, Deng Z, Chen F, Zheng L, Pan Y, Xing Q, et al
Regarding liver and kidney damage in MTX treatment, Bedoui stated that MTX hepatotoxicity may occur due to the depletion of folate reserves and MTX-polyglutamate formation in the liver (Reference Bedoui, Guillot and Slambarom41)